• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Vaccine Hesitancy: Clarifying a Theoretical Framework for an Ambiguous Notion
Conclusion In this paper, we have discussed some of the ambiguities and contradictions of the notion of vaccine hesitancy. We have argued that it is currently more a catchall category than a real concept. This lack of consistence is likely to hamper both research and interventions. Therefore, as a supplement to the previous work carried out by the SAGE working group, we propose grounding the notion of vaccine hesitancy in an explicit theoretical framework that takes some major structural features of contemporary societies into account. We consider VH to be a kind of decision-making process that depends on people’s level ...
Source: PLOS Currents Outbreaks - February 25, 2015 Category: Epidemiology Authors: patrick.peretti-watel at inserm.fr Source Type: research

Characteristics associated with use of homeopathic drugs for psychiatric symptoms in the general population.
CONCLUSION: Homeopathic treatment for psychiatric symptoms appears to be used mainly to reduce anxiety symptoms in the general population. PMID: 22153728 [PubMed - in process]
Source: Journal of the Association of European Psychiatrists - March 9, 2013 Category: Psychiatry Tags: Eur Psychiatry Source Type: research

Prescription of Complementary and Alternative Medicine (CAM) in an Italian Cohort of Pediatric Headache Patients (P03.115)
CONCLUSIONS: Our study shows that CAM is widely used among pediatric headache patients, and physicians are mostly unaware of prescription. Further studies are required to investigate safety and efficacy of CAM, as a possible side-medicine to conventional pharmacological approach.Disclosure: Dr. Colombo has nothing to disclose. Dr. Dalla Libera has nothing to disclose. Dr. Pavan has nothing to disclose. Dr. Comi has received personal compensation for activities with Novartis, Teva Neuroscience, Sanofi-Aventis Pharmaceuticals, Inc., Merck Serono, and Bayer Schering.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Colombo, B., Dalla Libera, D., Pavan, G., Comi, G. Tags: P03 Headache: Epidemiology Source Type: research